APC	Antigen-Presenting Cell
ATP	Adenosine TriPhosphate
BAP1	BRCA1-associated protein 1
BiTE	Bispecific T-cell Engager
CD	Cluster of Differentiation
c-MET	c-Mesenchymal-Epithelial Transition Factor
CT	Computerised Tomography
CTLA-4	Cytotoxic T-Lymphocyte Associated Protein 4
CYSLTR2	Cysteinyl Leukotriene Receptor 2
CXCL	Chemokine (C-X-C motif) Ligand
CXCR3	C-X-C Chemokine Receptor 3
EIF1AX	Initiation Factor 1A X-linked
FDA	Food and Drug Administration
FNA	Fine Needle Aspiration
GAGs	Glycosaminoglycans
GNA11	Guanosine Nucleotide-Binding Protein Alpha-11
GNAQ	Guanosine Nucleotide-Binding Protein Alpha-Q Gene
gp100	Glycoprotein 100
HDAC	Histone Deacetylase
HLA	Human Leukocyte Antigen
HR	Hazard Ratio
ICI	Immune Checkpoint Inhibitor
IV	Intravenous
LAG3	Lymphocyte Activation Gene 3
mAb	Monoclonal Antibody
MBD4	Methyl-CpG Binding Domain Protein 4
MEK	Mitogen-Activated Extracellular Signal-Regulated Kinase
MET	Mesenchymal-Epithelial Transition Factor
MHC	Major Histocompatibility Complex
MRI	Magnetic Resonance Imaging
MS	Median Survival
mTKI	Multitargeted Tyrosine Kinase Inhibitors
mUM	Metastatic Uveal Melanoma
OS	Overall Survival
PD-1	Programmed Cell Death Protein 1
PD-L1	Programmed Death-Ligand 1
PHP	Percutaneous Hepatic Perfusion
PI3K	Phosphoinositide 3-Kinase
PI3Kδ	Phosphoinositide 3-kinase delta
PKC	Protein Kinase C
PLCB4	Phospholipase C Beta 4 (PLCB4)
PV	Papillomaviruses
SF3B1	Splicing Factor 3B Subunit 1
SIRT	Selective Internal Radiotherapy
SRSF2	Serine and Arginine Rich Splicing Factor 2
TACE	Transarterial Chemoembolization
TCR	T-cell Receptor
TEBE	Tebentafusp
TMB	Tumour Mutational Burden
UM	Uveal Melanoma
UVR	Ultraviolet Radiation
VEGF	Vascular Endothelial Growth Factor
VLP	Viral-Like Particles